{"id":"https://openalex.org/W200877045","doi":null,"title":"Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.","display_name":"Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.","publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W200877045","mag":"200877045","pmid":"https://pubmed.ncbi.nlm.nih.gov/10953341"},"language":"en","primary_location":{"id":"pmid:10953341","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10953341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052277840","display_name":"B B\u00f6dey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1174212","display_name":"University of Southern California","ror":"https://ror.org/03taz7m60","country_code":"US","type":"education","lineage":["https://openalex.org/I1174212"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Bodey","raw_affiliation_strings":["Department of Pathology, University of Southern California, Los Angeles 91335, USA. Bodey18@aol.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, University of Southern California, Los Angeles 91335, USA. Bodey18@aol.com","institution_ids":["https://openalex.org/I1174212"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109119926","display_name":"B Bodey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B Bodey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111391869","display_name":"S E Siegel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S E Siegel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"H E Kaiser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H E Kaiser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2796,"has_fulltext":false,"cited_by_count":141,"citation_normalized_percentile":{"value":0.92273556,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"20","issue":"4","first_page":"2665","last_page":"76"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9369999766349792},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.9190000295639038},{"id":"https://openalex.org/keywords/mhc-downregulation","display_name":"MHC downregulation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/costimulatory-molecules","display_name":"costimulatory molecules","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dendritic-cell-vaccine","display_name":"dendritic cell vaccine","score":0.828000009059906},{"id":"https://openalex.org/keywords/anti-idiotype-vaccine","display_name":"anti-idiotype vaccine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/whole-cell-vaccine","display_name":"whole-cell vaccine","score":0.7480000257492065},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.5049999952316284},{"id":"https://openalex.org/keywords/tumor-progression","display_name":"tumor progression","score":0.5180000066757202},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.41200000047683716},{"id":"https://openalex.org/keywords/hla-restriction","display_name":"HLA restriction","score":0.4869999885559082},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.3889999985694885},{"id":"https://openalex.org/keywords/vaccine-failure","display_name":"vaccine failure","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.7218759059906006},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6752058267593384},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6599237322807312},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.6203125715255737},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5902197360992432},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.589537501335144},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5741925835609436},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5562493801116943},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5243507027626038},{"id":"https://openalex.org/C2778378633","wikidata":"https://www.wikidata.org/wiki/Q2378309","display_name":"Cancer vaccine","level":4,"score":0.5063296556472778},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4954119920730591},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4862779378890991},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.46608370542526245},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.45527026057243347},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.44872161746025085},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4102691113948822},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.21663835644721985},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09172260761260986},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006433","descriptor_name":"Hemocyanins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014614","descriptor_name":"Vaccines, Synthetic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016213","descriptor_name":"Cyclins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018394","descriptor_name":"CA-125 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018396","descriptor_name":"Mucin-1","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050759","descriptor_name":"Cyclin-Dependent Kinase Inhibitor p21","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10953341","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10953341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:200877045","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10953341","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2016825231","https://openalex.org/W1541149498","https://openalex.org/W2093808272","https://openalex.org/W4244739920","https://openalex.org/W2163239191","https://openalex.org/W2109011302","https://openalex.org/W4394845618","https://openalex.org/W570360169","https://openalex.org/W4406234147","https://openalex.org/W2313117624"],"abstract_inverted_index":{"Immunotherapy":[0],"has":[1,296,306],"always":[2,227],"represented":[3],"a":[4,93,320,346],"very":[5,261,339],"attractive":[6],"fourth-modality":[7],"therapeutic":[8],"approach,":[9],"especially":[10,57],"in":[11,23,58,174,202,237,275,299,303,385,400,458],"light":[12],"of":[13,17,26,29,50,109,112,117,123,141,161,205,218,230,257,324,328,357,359,381,392,403,420,433,438,461,468],"the":[14,24,48,84,87,98,106,115,139,173,216,228,241,245,288,293,338,350,354,382,393,397,401,404,412,429,459,469],"many":[15],"shortcomings":[16],"conventional":[18],"surgery,":[19],"radiation,":[20],"and":[21,150,157,182,247,311,314,343,411,427,457],"chemotherapies":[22],"management":[25,460],"cancer.":[27],"Subsets":[28],"neoplastically":[30,99,362],"transformed":[31,100,363],"cells":[32,395,422],"have":[33,72,134,192,269,278],"been":[34,73,135,194,279,297,308],"shown":[35],"to":[36,79,105,178,214,220,240,331,337,353,390,445,448,453],"(re-)express":[37],"on":[38,47,83,187],"their":[39,333,449],"surface":[40,49],"molecules":[41],"which":[42,165,196,234,365],"are":[43,129,367],"not":[44,307],"typically":[45],"present":[46],"neighboring":[51],"normal":[52],"cells.":[53],"In":[54],"some":[55],"instances,":[56],"malignant":[59],"melanomas,":[60],"cytotoxic":[61],"T":[62,222],"lymphocytes":[63],"(CTLs)":[64],"directed":[65,286],"against":[66,97,287],"such":[67,127,162,386],"tumor":[68,154,250,304,312,421],"associated":[69,190],"antigens":[70,242,290],"(TAAs)":[71],"isolated.":[74],"The":[75,252,326,416,436],"cancer":[76,188,294,329,375,430,439,471],"vaccine":[77,295,431],"approach":[78],"therapy":[80],"is":[81,226,260,335,432],"based":[82,186],"notion":[85],"that":[86,370],"immune":[88,180,207,284,383],"system":[89,384],"could":[90,235],"possibly":[91,318],"mount":[92],"rejection":[94],"strength":[95],"response":[96],"cell":[101,155,189,210,376],"conglomerate.":[102],"However,":[103],"due":[104,336],"low":[107],"immunogenicity":[108,200],"TAAs,":[110],"downregulation":[111],"MHC":[113],"molecules,":[114],"lack":[116,424],"adequate":[118],"costimulatory":[119,169,414],"molecule":[120],"expression,":[121],"secretion":[122],"immunoinhibitory":[124],"cytokines,":[125],"etc.,":[126],"expectations":[128],"rarely":[130],"fulfilled.":[131],"Various":[132],"approaches":[133,259],"explored":[136,195],"ranging":[137],"from":[138,147],"use":[140,437],"irradiation":[142],"inactivated":[143],"whole-cell":[144],"vaccines":[145,164,212,330,440],"derived":[146],"both":[148,454],"autologous":[149],"allogeneic":[151],"tumors":[152],"(even":[153],"lines),":[156],"genetically":[158],"modified":[159],"versions":[160],"cellular":[163],"aim":[166,197],"at":[167,198,442],"correcting":[168],"dysfunction":[170],"or":[171],"altering":[172],"situ":[175],"humoral":[176],"milieu":[177],"aid":[179],"recognition":[181],"activation.":[183],"Anti-idiotype":[184],"vaccines,":[185],"idiotypes,":[191],"also":[193],"increasing":[199],"through":[201,345],"vivo":[203],"generation":[204],"vigorous":[206],"responses.":[208],"Dendritic":[209],"(DC)":[211],"seek":[213],"improve":[215],"presentation":[217,233],"TAAs":[219,399],"naive":[221],"lymphocytes.":[223],"Unfortunately,":[224],"there":[225],"possibility":[229],"faulty":[231],"antigen":[232,408],"result":[236],"tolerance":[238],"induction":[239],"contained":[243,291],"within":[244,292],"vaccine,":[246],"subsequent":[248],"rapid":[249],"progression.":[251],"theoretical":[253],"basis":[254],"for":[255],"all":[256],"these":[258,425],"well":[262],"founded.":[263],"Animal":[264],"models,":[265],"albeit":[266],"highly":[267,360],"artificial,":[268],"yielded":[270],"promising":[271],"results.":[272],"Clinical":[273],"trials":[274],"humans,":[276],"however,":[277],"somewhat":[280],"disappointing.":[281],"Although":[282],"general":[283],"activation":[285,380],"target":[289],"documented":[298],"most":[300,417],"cases,":[301],"reduction":[302],"load":[305],"frequently":[309],"observed,":[310],"progression":[313],"metastasis":[315],"usually":[316],"ensue,":[317],"following":[319,465],"slightly":[321],"extended":[322],"period":[323],"remission.":[325],"failure":[327],"fulfill":[332],"promise":[334],"relationship":[340],"between":[341],"host":[342,351],"tumor:":[344],"natural":[347],"selection":[348],"process":[349],"leads":[352,389],"selective":[355],"enrichment":[356],"clones":[358,419],"aggressive":[361],"cells,":[364],"apparently":[366],"so":[368],"dedifferentiated":[369],"they":[371],"no":[372],"longer":[373],"express":[374],"specific":[377],"molecules.":[378,415],"Specific":[379],"cases":[387],"only":[388],"lysis":[391],"remaining":[394],"expressing":[396],"particular":[398,405],"context":[402],"human":[406],"leukocyte":[407],"(HLA)":[409],"subclass":[410],"necessary":[413],"dangerous":[418],"however":[423],"features":[426],"thus":[428],"little":[434],"use.":[435],"seems,":[441],"present,":[443],"destined":[444],"remain":[446],"limited":[447],"employment":[450],"as":[451],"adjuvants":[452],"traditional":[455],"therapies":[456],"minimal":[462],"residual":[463],"disease":[464],"surgical":[466],"resection":[467],"primary":[470],"mass.":[472]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}